ISSN: 0893-0341
Journal Home
Journal Guideline
Alzheimer Disease and Associated Disorders Q2 Unclaimed
Alzheimer Disease and Associated Disorders is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 109. It has an SJR impact factor of 0,609 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,609.
Alzheimer Disease and Associated Disorders focuses its scope in these topics and keywords: alzheimer, impairment, cognitive, disease, mild, framingham, gait, hippocampal, hyperintensities, frontal, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,609
SJR Impact factor109
H Index64
Total Docs (Last Year)191
Total Docs (3 years)1832
Total Refs341
Total Cites (3 years)185
Citable Docs (3 years)1.64
Cites/Doc (2 years)28.63
Ref/DocOther journals with similar parameters
Psychiatric Quarterly Q2
International Journal of Methods in Psychiatric Research Q2
Revista Brasileira de Psiquiatria Q2
International Review of Psychiatry Q2
Behavioral Medicine Q2
Compare this journals
Aims and Scope
Best articles by citations
Magnetic Resonance in Dementia
View moreCholinesterases and the Pathology of Alzheimer Disease
View moreYounger Age at Crisis Following Parental Death in Male Children and Adolescents Is Associated With Higher Risk for Dementia at Old Age
View moreValidity of Death Certificate and Hospital Discharge ICD Codes for Dementia Diagnosis
View moreEffectiveness of a Psychoeducational Intervention Group Program in the Reduction of the Burden Experienced by Caregivers of Patients With Dementia
View moreHarmonization of Dementia Drug Guidelines (United States and Europe): A Report of the International Working Group for the Harmonization for Dementia Drug Guidelines
View moreProxy Decision Making in Alzheimer Disease Research
View moreScreening for Cognitive Impairment in General Practice
View moreIntroduction
View moreAnosognosia in Alzheimer Disease
View moreEffect of a Combined Walking and Conversation Intervention on Functional Mobility of Nursing Home Residents With Alzheimer Disease
View moreAge at Onset and Visuocognitive Disturbances in Alzheimer Disease
View moreTheory of Mind and Recognition of Facial Emotion in Dementia
View moreAlzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI
View moreAlzheimer Disease: Absolute Quantification of Cerebral Metabolites In Vivo Using Localized Proton Magnetic Resonance Spectroscopy
View moreAlzheimer Disease: Current Therapy and Future Therapeutic Strategies
View moreDetermining the Competency of Alzheimer Patients to Consent to Treatment and Research
View moreHealth-Related Quality of Life for Caregivers of Patients With Alzheimer Disease
View moreMedicare Expenditures Associated with Alzheimer Disease
View moreRandomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Metrifonate in Patients with Probable Alzheimer Disease
View moreCurrent Status of Clinical Trials for Alzheimer-Type Dementia in Japan: Strategies to Facilitate the Development of Antidementia Drugs
View moreAutopsy Practices at CERAD and Alzheimer Disease Center Sites
View moreAutopsy Recruitment Program for African Americans
View moreThe Rest-Activity Rhythm and Physical Activity in Early-Onset Dementia
View more
Comments